Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device)), Diagnostic (PSG, Oximeter), End User (Sleep Laboratories & Hospitals, Home Care Settings/Individuals) - Global Forecasts to 2024

睡眠時無呼吸症候群用装置の世界市場予測(~2024年)

◆タイトル:Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device)), Diagnostic (PSG, Oximeter), End User (Sleep Laboratories & Hospitals, Home Care Settings/Individuals) - Global Forecasts to 2024
◆商品コード:MD 1181
◆調査・発行会社:MarketsandMarkets
◆発行日:2019年5月25日
◆ページ数:256
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧)USD5,650 ⇒換算¥649,750見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥764,750見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥937,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

睡眠時無呼吸症候群用装置の世界市場は、2019年の45億米ドルから2024年には75億米ドルに達し、この期間中10.7%の年平均成長率で成長すると予測されています。この市場の成長を促す要因として、未診断の睡眠時無呼吸症候群患者の予備軍の存在、未治療の睡眠時無呼吸症候群の悪影響についての意識の高まり、口腔ケア器具の使用の増加、睡眠時無呼吸症候群用装置の技術的進歩、ベンチャーキャピタルからの資金調達の増加、および睡眠時無呼吸症候群や口腔ケア機器市場に参入する企業の増加が考えられます。一方で、CPAPマシンの高コスト、複雑な照会パス、長い待機期間が市場の成長にとっての制約となる可能性があります。当調査レポートでは、睡眠時無呼吸症候群用装置の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、産業動向、市場シェア分析、種類(治療装置、診断装置)別分析、エンドユーザー(睡眠研究所・病院、在宅医療・個人)別分析、睡眠時無呼吸症候群用装置の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The sleep apnea devices market is projected to grow at a CAGR of 10.7% during the forecast period.”The global sleep apnea devices market is projected to reach 7.5 billion by 2024 from USD 4.5 billion in 2019 at a CAGR of 10.7%. Growth in the sleep apnea devices market can be attributed to factors such as the large pool of undiagnosed sleep apnea patients, growing awareness about the ill effects of untreated sleep apnea, growing usage of oral appliances, technological advancements in sleep apnea devices, considerable venture capital funding, and the increasing number of companies venturing into sleep apnea and oral appliances markets. However, the high cost of CPAP machines and complex referral pathways & long waiting periods may prove to be restraints for the market.

“The therapeutic devices segment is expected to hold the largest market share during the forecast period.”
On the basis of type, the sleep apnea devices market has been segmented into therapeutic devices and diagnostic devices. The therapeutic devices segment accounted for the largest share of the market during the forecast period and is projected to register the highest CAGR. The large share and high growth in the therapeutic devices segment can be attributed to the increasing pool of undiagnosed sleep apnea patients and the improving reimbursement scenario for these devices across the globe.

“The sleep laboratories & hospitals segment accounted for the largest share in 2018.”
On the basis of end user, the sleep apnea devices market has been segmented into sleep laboratories & hospitals and home care settings/individuals. The sleep laboratories & hospitals segment commanded the largest share of the market in 2018 while home care settings/individuals end-user segment is estimated to grow at the highest CAGR during the forecast period; The high growth of the home care settings/individuals’ segment can be attributed to factors such as increasing preference for home sleep testing by both patients and insurance companies, coupled with the favorable reimbursement scenario for home sleep testing.

“The Asia Pacific region of the sleep apnea devices market is expected to grow at the highest rate during the forecast period.”
Geographically, the sleep apnea devices market is segmented into North America, Europe, Asia Pacific (APAC), and the Rest of the World. The Asia Pacific market is expected to grow at the highest rate during the forecast period. Higher growth in this region is attributed to factors like the presence of a large undiagnosed patient pool in countries such as India, strategic agreements between global market leaders and regional players, and initiatives undertaken by government and other private organizations to raise awareness regarding sleep disorders in this region.

Breakdown of supply-side primary interviews:
• By Company Type: Tier 1 – 55%, Tier 2 – 40%, and Tier 3 – 5%
• By Designation: C-level – 37%, Director-level – 48%, and Others – 15%
• By Region: North America – 56%, Europe – 20%, APAC – 17%, and RoW – 7%

Major players in the market include ResMed (US), Koninklijke Philips (Netherlands), Fisher & Paykel Healthcare (New Zealand), SomnoMed (US), Oventus Medical (Australia), Compumedics (Australia), Löwenstein Medical (Germany), Drive DeVilbiss Healthcare (US), BMC Medical (China), Braebon Medical (Canada), and Panthera Dental (Canada).

Research Coverage
This report studies the sleep apnea devices market based on type, end user, and region. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes the opportunities and challenges in the market and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to four main regions and respective countries.

Key Benefits of Buying the Report
This report focuses on various levels of analysis—industry trends, market share of top players, and company profiles, which together form basic views and analyze the competitive landscape, emerging segments of the sleep apnea devices market, and high-growth regions and their drivers, restraints, challenges, and opportunities. The report will help both established firms as well as new entrants/smaller firms to gauge the pulse of the market and garner greater market shares.

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.3 MARKET SCOPE 22
1.3.1 MARKETS COVERED 23
1.3.2 YEARS CONSIDERED FOR THE STUDY 23
1.4 CURRENCY 24
1.5 LIMITATIONS 24
1.6 STAKEHOLDERS 24
2 RESEARCH METHODOLOGY 25
2.1 RESEARCH DATA 25
2.1.1 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 27
2.1.1.1 Secondary research 27
2.1.1.1.1 Key data from secondary sources 27
2.1.1.2 Primary research 28
2.1.1.2.1 Key data from primary sources 29
2.1.1.2.2 Key insights from primary sources 30
2.1.2 MARKET SIZE ESTIMATION METHODOLOGY 30
2.2 MARKET DATA VALIDATION AND TRIANGULATION 32
2.3 ASSUMPTIONS FOR THE STUDY 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 38
4.1 SLEEP APNEA DEVICES: MARKET OVERVIEW 38
4.2 SLEEP APNEA DEVICES MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION) 39
4.3 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY TYPE,
2019 VS. 2024 (USD MILLION) 39
4.4 SLEEP APNEA DEVICES MARKET SHARE, BY END USER (2019 VS. 2024) 40
4.5 GEOGRAPHICAL SNAPSHOT OF THE SLEEP APNEA DEVICES MARKET 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 Large pool of undiagnosed sleep apnea patients 43
5.2.1.2 Growing awareness about the ill effects of untreated sleep apnea 43
5.2.1.3 Growing usage of oral appliances 45
5.2.1.4 Technological advancements in sleep apnea devices 45
5.2.1.5 Considerable venture capital funding 48
5.2.1.6 Increasing number of companies venturing into the sleep apnea and oral appliances markets 48
5.2.2 RESTRAINTS 49
5.2.2.1 High cost of CPAP machines 49
5.2.2.2 Complex referral pathways and long waiting periods 49
5.2.3 OPPORTUNITIES 49
5.2.3.1 Growing demand for home healthcare 49
5.2.3.2 Increasing focus on telemedicine and mHealth (mobile health) 50
5.2.4 CHALLENGES 50
5.2.4.1 Lack of patient compliance 50
6 EPIDEMIOLOGICAL ASSESSMENT OF SLEEP APNEA 51
6.1 INTRODUCTION 51
6.2 EPIDEMIOLOGICAL ASSESSMENT 51
6.3 PRESCRIPTION PATTERN ASSESSMENT 52
6.4 ADHERENCE ASSESSMENT 53
7 ALTERNATE THERAPIES FOR SLEEP APNEA 55
7.1 INTRODUCTION 55
7.2 EXPIRATORY POSITIVE AIRWAY PRESSURE 55
7.3 HYPOGLOSSAL NERVE STIMULATION 55
7.4 ORAL PRESSURE THERAPY 56
7.5 POSITIONAL THERAPY 56
8 SLEEP APNEA DEVICES MARKET, BY TYPE 58
8.1 INTRODUCTION 59
8.2 THERAPEUTIC DEVICES 60
8.2.1 POSITIVE AIRWAY PRESSURE DEVICES 61
8.2.1.1 PAP devices dominate the therapeutic devices market 61
8.2.1.1.1 Automatic positive airway pressure devices 62
8.2.1.1.2 Continuous positive airway pressure devices 63
8.2.1.1.3 Bilevel positive airway pressure devices 64
8.2.2 FACIAL INTERFACES 65
8.2.2.1 Role of facial interfaces in increasing CPAP compliance is expected to drive market growth 65
8.2.2.1.1 Masks 66
8.2.2.1.1.1 Full-face masks 67
8.2.2.1.1.2 Nasal pillow masks 68
8.2.2.1.1.3 Nasal masks 69
8.2.2.2 Cushions 70

8.2.3 ACCESSORIES 70
8.2.3.1 The growth of the accessories segment is tied to the devices market 70
8.2.4 ORAL APPLIANCES 75
8.2.4.1 Advantages of oral appliances, such as comfort and small size, have driven their use 75
8.2.4.1.1 Mandibular advancement devices 76
8.2.4.1.2 Tongue-retaining devices 77
8.2.5 ADAPTIVE SERVO-VENTILATORS 77
8.2.5.1 Studies demonstrating the significance of ASV in improving clinical outcomes are expected to fuel market growth 77
8.2.6 OTHER THERAPEUTIC DEVICES 78
8.3 DIAGNOSTIC DEVICES 79
8.3.1 POLYSOMNOGRAPHY DEVICES 81
8.3.1.1 PSG tests are considered the gold standard for the diagnosis of sleep-related breathing disorders 81
8.3.1.1.1 Ambulatory PSG devices 82
8.3.1.1.2 Clinical PSG devices 82
8.3.2 HOME SLEEP TESTING DEVICES 83
8.3.2.1 Cost-effectiveness of home-based sleep tests expected to fuel the growth of home sleep testing devices 83
8.3.3 OXIMETERS 84
8.3.3.1 Oximeters help in preoperative monitoring and are commonly used in clinics 84
8.3.3.1.1 Fingertip oximeters 85
8.3.3.1.2 Handheld oximeters 86
8.3.3.1.3 Wrist-worn oximeters 87
8.3.3.1.4 Tabletop oximeters 87
8.3.4 ACTIGRAPHY SYSTEMS 88
8.3.4.1 Increasing focus on assessing actimeter performance will contribute to market growth 88
8.3.5 SLEEP SCREENING DEVICES 89
8.3.5.1 Rising preference for home-based testing is driving the use of sleep screening devices 89
9 SLEEP APNEA DEVICES MARKET, BY END USER 90
9.1 INTRODUCTION 91
9.2 SLEEP LABORATORIES & HOSPITALS 92
9.2.1 INCREASING NUMBER OF SLEEP LABS GLOBALLY TO DRIVE THE GROWTH OF THIS END-USER SEGMENT 92
9.3 HOME CARE SETTINGS/INDIVIDUALS 93
9.3.1 RISE IN PREFERENCE OF PATIENTS AND INSURANCE COMPANIES FOR HOME-BASED SLEEP TESTS IS EXPECTED TO FUEL MARKET GROWTH 93

10 SLEEP APNEA DEVICES MARKET, BY REGION 95
10.1 INTRODUCTION 96
10.2 NORTH AMERICA 98
10.2.1 US 105
10.2.1.1 US dominated the North American sleep apnea devices market in 2018 105
10.2.2 CANADA 111
10.2.2.1 Rise in the number of grants awarded to research organizations – A major factor driving market growth in Canada 111
10.3 EUROPE 117
10.3.1 GERMANY 123
10.3.1.1 The prevalence of OSA in Germany is among the highest in Europe 123
10.3.2 FRANCE 129
10.3.2.1 Rising geriatric population to increase the prevalence of sleep apnea in France 129
10.3.3 UK 134
10.3.3.1 Increasing number of awareness initiatives to support market growth in the UK 134
10.3.4 ITALY 139
10.3.4.1 Government initiatives for improving care for sleep apnea patients to drive market growth in Italy 139
10.3.5 SPAIN 145
10.3.5.1 Initiatives by regional organizations to support market growth in Spain 145
10.3.6 REST OF EUROPE 151
10.4 ASIA PACIFIC 157
10.4.1 JAPAN 164
10.4.1.1 Changing reimbursement scenario to drive market growth in Japan 164
10.4.2 CHINA 170
10.4.2.1 Growing adult obesity rates to increase the prevalence of sleep apnea in China 170
10.4.3 AUSTRALIA 176
10.4.3.1 Continuous technological advancements by regional players to drive market growth in Australia 176
10.4.4 ROAPAC 182
10.5 REST OF THE WORLD 188
10.6 LATIN AMERICA 195
10.6.1 RISING OBESITY RATE TO INCREASE THE PREVALENCE OF SLEEP APNEA IN LATAM 195
10.7 MIDDLE EAST AND AFRICA 201
10.7.1 LOW AWARENESS ABOUT SLEEP APNEA TO RESTRAIN MARKET GROWTH IN THE MIDDLE EAST AND AFRICA 201

11 COMPETITIVE LANDSCAPE 207
11.1 OVERVIEW 207
11.2 MARKET SHARE ANALYSIS 208
11.2.1 INTRODUCTION 208
11.3 COMPETITIVE LEADERSHIP MAPPING 209
11.3.1 VISIONARY LEADERS 209
11.3.2 INNOVATORS 209
11.3.3 DYNAMIC DIFFERENTIATORS 209
11.3.4 EMERGING COMPANIES 209
11.4 COMPETITIVE SCENARIO 211
11.4.1 PRODUCT LAUNCHES 211
11.4.2 ACQUISITIONS 211
11.4.3 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 212
12 COMPANY PROFILES 213
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 RESMED 213
12.2 KONINKLIJKE PHILIPS 219
12.3 FISHER & PAYKEL HEALTHCARE 224
12.4 SOMNOMED 227
12.5 OVENTUS MEDICAL 229
12.6 COMPUMEDICS 232
12.7 LÖWENSTEIN MEDICAL 235
12.8 DRIVE DEVILBISS HEALTHCARE 237
12.9 BMC MEDICAL 239
12.10 BRAEBON MEDICAL CORPORATION 241
12.11 WHOLE YOU 242
12.12 PANTHERA DENTAL 243

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.
13 APPENDIX 244
13.1 DISCUSSION GUIDE 244
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 247
13.3 AVAILABLE CUSTOMIZATIONS 249
13.4 RELATED REPORTS 249
13.5 AUTHOR DETAILS 250

LIST OF TABLES

TABLE 1 INITIATIVES TO PROMOTE AWARENESS ABOUT THE ILL EFFECTS OF UNTREATED SLEEP APNEA 44
TABLE 2 RECENT TECHNOLOGICAL ADVANCEMENTS IN SLEEP APNEA DEVICES 46
TABLE 3 SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 59
TABLE 4 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 60
TABLE 5 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 61
TABLE 6 PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 62
TABLE 7 PAP DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 62
TABLE 8 APAP DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 63
TABLE 9 CPAP DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 64
TABLE 10 BPAP DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 65
TABLE 11 FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 65
TABLE 12 FACIAL INTERFACES MARKET, BY REGION, 2017–2024 (USD MILLION) 66
TABLE 13 MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 67
TABLE 14 MASKS MARKET, BY REGION, 2017–2024 (USD MILLION) 67
TABLE 15 FULL-FACE MASKS MARKET, BY REGION, 2017–2024 (USD MILLION) 68
TABLE 16 NASAL PILLOW MASKS MARKET, BY REGION, 2017–2024 (USD MILLION) 69
TABLE 17 NASAL MASKS MARKET, BY REGION, 2017–2024 (USD MILLION) 69
TABLE 18 CUSHIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 70
TABLE 19 ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 71
TABLE 20 ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION) 71
TABLE 21 HUMIDIFIER ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION) 72
TABLE 22 POWER ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION) 72
TABLE 23 TRANSPORTATION ACCESSORIES MARKET, BY REGION,
2017–2024 (USD MILLION) 73
TABLE 24 COMMUNICATION ACCESSORIES MARKET, BY REGION,
2017–2024 (USD MILLION) 73
TABLE 25 CHIN RESTRAINTS MARKET, BY REGION, 2017–2024 (USD MILLION) 74
TABLE 26 OTHER ACCESSORIES MARKET, BY REGION, 2017–2024 (USD MILLION) 74
TABLE 27 ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 75
TABLE 28 ORAL APPLIANCES MARKET, BY REGION, 2017–2024 (USD MILLION) 76
TABLE 29 MANDIBULAR ADVANCEMENT DEVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 76
TABLE 30 TONGUE-RETAINING DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 77
TABLE 31 ADAPTIVE SERVO-VENTILATORS MARKET, BY REGION, 2017–2024 (USD MILLION) 78
TABLE 32 OTHER THERAPEUTIC DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 79
TABLE 33 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 80
TABLE 34 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY REGION,
2017–2024 (USD MILLION) 80
TABLE 35 PSG DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 81
TABLE 36 PSG DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 81
TABLE 37 AMBULATORY PSG DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 82
TABLE 38 CLINICAL PSG DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 83
TABLE 39 HOME SLEEP TESTING DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 84
TABLE 40 OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 84
TABLE 41 OXIMETERS MARKET, BY REGION, 2017–2024 (USD MILLION) 85
TABLE 42 FINGERTIP OXIMETERS MARKET, BY REGION, 2017–2024 (USD MILLION) 86
TABLE 43 HANDHELD OXIMETERS MARKET, BY REGION, 2017–2024 (USD MILLION) 86
TABLE 44 WRIST-WORN OXIMETERS MARKET, BY REGION, 2017–2024 (USD MILLION) 87
TABLE 45 TABLETOP OXIMETERS MARKET, BY REGION, 2017–2024 (USD MILLION) 88
TABLE 46 ACTIGRAPHY SYSTEMS MARKET, BY REGION, 2017–2024 (USD MILLION) 89
TABLE 47 SLEEP SCREENING DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 89
TABLE 48 SLEEP APNEA DEVICES MARKET, BY END USER, 2017–2024 (USD MILLION) 91
TABLE 49 SLEEP APNEA DEVICES MARKET FOR SLEEP LABORATORIES & HOSPITALS,
BY REGION, 2017–2024 (USD MILLION) 93
TABLE 50 SLEEP APNEA MARKET FOR HOME CARE SETTINGS/INDIVIDUALS,
BY REGION, 2017–2024 (USD MILLION) 94
TABLE 51 SLEEP APNEA DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 97
TABLE 52 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 99
TABLE 53 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 99
TABLE 54 NORTH AMERICA: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 100
TABLE 55 NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 100
TABLE 56 NORTH AMERICA: FACIAL INTERFACES MARKET, BY TYPE,
2017–2024 (USD MILLION) 101
TABLE 57 NORTH AMERICA: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 101
TABLE 58 NORTH AMERICA: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 102
TABLE 59 NORTH AMERICA: ORAL APPLIANCES MARKET, BY TYPE,
2017–2024 (USD MILLION) 102
TABLE 60 NORTH AMERICA: DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 103
TABLE 61 NORTH AMERICA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 103
TABLE 62 NORTH AMERICA: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 104
TABLE 63 NORTH AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 104
TABLE 64 US: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 106
TABLE 65 US: THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 106
TABLE 66 US: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 107
TABLE 67 US: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 107
TABLE 68 US: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 107
TABLE 69 US: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 108
TABLE 70 US: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 108
TABLE 71 US: DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 109
TABLE 72 US: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 109
TABLE 73 US: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 110
TABLE 74 US: SLEEP APNEA DEVICES MARKET, BY END USER, 2017–2024 (USD MILLION) 110
TABLE 75 CANADA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 111
TABLE 76 CANADA: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 112
TABLE 77 CANADA: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 112
TABLE 78 CANADA: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 113
TABLE 79 CANADA: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 113
TABLE 80 CANADA: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 114
TABLE 81 CANADA: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 114
TABLE 82 CANADA: DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 115
TABLE 83 CANADA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 115
TABLE 84 CANADA: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 116
TABLE 85 CANADA: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 116
TABLE 86 EUROPE: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 118
TABLE 87 EUROPE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 118
TABLE 88 EUROPE: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 119
TABLE 89 EUROPE: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 119
TABLE 90 EUROPE: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 120
TABLE 91 EUROPE: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 120
TABLE 92 EUROPE: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 121
TABLE 93 EUROPE: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 121
TABLE 94 EUROPE: DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 122
TABLE 95 EUROPE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 122
TABLE 96 EUROPE: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 123
TABLE 97 EUROPE: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 123
TABLE 98 GERMANY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 124
TABLE 99 GERMANY: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 124
TABLE 100 GERMANY: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 125
TABLE 101 GERMANY: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 125
TABLE 102 GERMANY: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 125
TABLE 103 GERMANY: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 126
TABLE 104 GERMANY: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 126
TABLE 105 GERMANY: DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 127
TABLE 106 GERMANY: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 127
TABLE 107 GERMANY: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 128
TABLE 108 GERMANY: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 128
TABLE 109 FRANCE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 129
TABLE 110 FRANCE: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 130
TABLE 111 FRANCE: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 130
TABLE 112 FRANCE: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 131
TABLE 113 FRANCE: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 131
TABLE 114 FRANCE: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 132
TABLE 115 FRANCE: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 132
TABLE 116 FRANCE: DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 133
TABLE 117 FRANCE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 133
TABLE 118 FRANCE: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 134
TABLE 119 FRANCE: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 134
TABLE 120 UK: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 135
TABLE 121 UK: THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 135
TABLE 122 UK: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 136
TABLE 123 UK: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 136
TABLE 124 UK: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 136
TABLE 125 UK: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 137
TABLE 126 UK: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 137
TABLE 127 UK: DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 138
TABLE 128 UK: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 138
TABLE 129 UK: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 139
TABLE 130 UK: SLEEP APNEA DEVICES MARKET, BY END USER, 2017–2024 (USD MILLION) 139
TABLE 131 ITALY: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 140
TABLE 132 ITALY: THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 140
TABLE 133 ITALY: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 141
TABLE 134 ITALY: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 141
TABLE 135 ITALY: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 142
TABLE 136 ITALY: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 142
TABLE 137 ITALY: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 143
TABLE 138 ITALY: DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 143
TABLE 139 ITALY: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 144
TABLE 140 ITALY: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 144
TABLE 141 ITALY: SLEEP APNEA DEVICES MARKET, BY END USER, 2017–2024 (USD MILLION) 145
TABLE 142 SPAIN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 145
TABLE 143 SPAIN: THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 146
TABLE 144 SPAIN: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 146
TABLE 145 SPAIN: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 147
TABLE 146 SPAIN: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 147
TABLE 147 SPAIN: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 148
TABLE 148 SPAIN: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 148
TABLE 149 SPAIN: DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 149
TABLE 150 SPAIN: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 149
TABLE 151 SPAIN: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 150
TABLE 152 SPAIN: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 150
TABLE 153 ROE: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 151
TABLE 154 ROE: THERAPEUTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 152
TABLE 155 ROE: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 152
TABLE 156 ROE: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 153
TABLE 157 ROE: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 153
TABLE 158 ROE: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 154
TABLE 159 ROE: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 154
TABLE 160 ROE: DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 155
TABLE 161 ROE: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 155
TABLE 162 ROE: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 156
TABLE 163 ROE: SLEEP APNEA DEVICES MARKET, BY END USER, 2017–2024 (USD MILLION) 156
TABLE 164 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY COUNTRY,
2017–2024 (USD MILLION) 158
TABLE 165 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 158
TABLE 166 ASIA PACIFIC: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 159
TABLE 167 ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 159
TABLE 168 ASIA PACIFIC: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 160
TABLE 169 ASIA PACIFIC: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 160
TABLE 170 ASIA PACIFIC: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 161
TABLE 171 ASIA PACIFIC: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 161
TABLE 172 ASIA PACIFIC: DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 162
TABLE 173 ASIA PACIFIC: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 162
TABLE 174 ASIA PACIFIC: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 163
TABLE 175 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 163
TABLE 176 JAPAN: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 164
TABLE 177 JAPAN: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 165
TABLE 178 JAPAN: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 165
TABLE 179 JAPAN: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 166
TABLE 180 JAPAN: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 166
TABLE 181 JAPAN: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 167
TABLE 182 JAPAN: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 167
TABLE 183 JAPAN: DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 168
TABLE 184 JAPAN: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 168
TABLE 185 JAPAN: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 169
TABLE 186 JAPAN: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 169
TABLE 187 CHINA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 170
TABLE 188 CHINA: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 171
TABLE 189 CHINA: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 171
TABLE 190 CHINA: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 172
TABLE 191 CHINA: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 172
TABLE 192 CHINA: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 173
TABLE 193 CHINA: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 173
TABLE 194 CHINA: DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 174
TABLE 195 CHINA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 174
TABLE 196 CHINA: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 175
TABLE 197 CHINA: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 175
TABLE 198 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 176
TABLE 199 AUSTRALIA: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 177
TABLE 200 AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 177
TABLE 201 AUSTRALIA: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 178
TABLE 202 AUSTRALIA: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 178
TABLE 203 AUSTRALIA: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 179
TABLE 204 AUSTRALIA: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 179
TABLE 205 AUSTRALIA: DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 180
TABLE 206 AUSTRALIA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 180
TABLE 207 AUSTRALIA: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 181
TABLE 208 AUSTRALIA: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 181
TABLE 209 ROAPAC: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 182
TABLE 210 ROAPAC: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 183
TABLE 211 ROAPAC: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 183
TABLE 212 ROAPAC: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 184
TABLE 213 ROAPAC: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 184
TABLE 214 ROAPAC: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 185
TABLE 215 ROAPAC: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 185
TABLE 216 ROAPAC: DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 186
TABLE 217 ROAPAC: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 186
TABLE 218 ROAPAC: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 187
TABLE 219 ROAPAC: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 187
TABLE 220 ROW: SLEEP APNEA DEVICES MARKET, BY REGION, 2017–2024 (USD MILLION) 189
TABLE 221 ROW: SLEEP APNEA DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 189
TABLE 222 ROW: THERAPEUTIC DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 190
TABLE 223 ROW: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 190
TABLE 224 ROW: FACIAL INTERFACES MARKET, BY TYPE, 2017–2024 (USD MILLION) 191
TABLE 225 ROW: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 191
TABLE 226 ROW: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 192
TABLE 227 ROW: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 192
TABLE 228 ROW: DIAGNOSTIC DEVICES MARKET, BY PRODUCT, 2017–2024 (USD MILLION) 193
TABLE 229 ROW: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 193
TABLE 230 ROW: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 194
TABLE 231 ROW: SLEEP APNEA DEVICES MARKET, BY END USER, 2017–2024 (USD MILLION) 194
TABLE 232 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 195
TABLE 233 LATIN AMERICA: THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 196
TABLE 234 LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2017–2024 (USD MILLION) 196
TABLE 235 LATIN AMERICA: FACIAL INTERFACES MARKET, BY TYPE,
2017–2024 (USD MILLION) 197
TABLE 236 LATIN AMERICA: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 197
TABLE 237 LATIN AMERICA: ACCESSORIES MARKET, BY TYPE, 2017–2024 (USD MILLION) 198
TABLE 238 LATIN AMERICA: ORAL APPLIANCES MARKET, BY TYPE, 2017–2024 (USD MILLION) 198
TABLE 239 LATIN AMERICA: DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2017–2024 (USD MILLION) 199
TABLE 240 LATIN AMERICA: POLYSOMNOGRAPHY DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 199
TABLE 241 LATIN AMERICA: OXIMETERS MARKET, BY TYPE, 2017–2024 (USD MILLION) 200
TABLE 242 LATIN AMERICA: SLEEP APNEA DEVICES MARKET, BY END USER,
2017–2024 (USD MILLION) 200
TABLE 243 MIDDLE EAST AND AFRICA: SLEEP APNEA DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 201
TABLE 244 MIDDLE EAST AND AFRICA: THERAPEUTIC DEVICES MARKET,
BY PRODUCT, 2017–2024 (USD MILLION) 202
TABLE 245 MIDDLE EAST AND AFRICA: PAP DEVICES MARKET, BY TYPE,
2017–2024 (USD MILLION) 202
TABLE 246 MIDDLE EAST AND AFRICA: FACIAL INTERFACES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 203
TABLE 247 MIDDLE EAST AND AFRICA: MASKS MARKET, BY TYPE, 2017–2024 (USD MILLION) 203
TABLE 248 MIDDLE EAST AND AFRICA: ACCESSORIES MARKET, BY TYPE,
2017–2024 (USD MILLION) 204
TABLE 249 MIDDLE EAST AND AFRICA: ORAL APPLIANCES MARKET, BY TYPE,
2017–2024 (USD MILLION) 204
TABLE 250 MIDDLE EAST AND AFRICA: DIAGNOSTIC DEVICES MARKET,
BY PRODUCT, 2017–2024 (USD MILLION) 205
TABLE 251 MIDDLE EAST AND AFRICA: POLYSOMNOGRAPHY DEVICES MARKET,
BY TYPE, 2017–2024 (USD MILLION) 205
TABLE 252 MIDDLE EAST AND AFRICA: OXIMETERS MARKET, BY TYPE,
2017–2024 (USD MILLION) 206
TABLE 253 MIDDLE EAST AND AFRICA: SLEEP APNEA DEVICES MARKET,
BY END USER, 2017–2024 (USD MILLION) 206
TABLE 254 PRODUCT LAUNCHES (2016–2019) 211
TABLE 255 ACQUISITIONS (2016–2019) 211
TABLE 256 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2016–2019) 212


LIST OF FIGURES

FIGURE 1 RESEARCH METHODOLOGY STEPS 25
FIGURE 2 RESEARCH DESIGN 26
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION,
AND REGION 29
FIGURE 4 BOTTOM-UP APPROACH 31
FIGURE 5 TOP-DOWN APPROACH 31
FIGURE 6 DATA TRIANGULATION METHODOLOGY 32
FIGURE 7 SLEEP APNEA DEVICES MARKET, BY TYPE, 2019 VS. 2024 (USD MILLION) 34
FIGURE 8 SLEEP APNEA THERAPEUTIC DEVICES MARKET, BY PRODUCT,
2019 VS. 2024 (USD MILLION) 35
FIGURE 9 SLEEP APNEA DIAGNOSTIC DEVICES MARKET, BY PRODUCT,
2019 VS. 2024 (USD MILLION) 35
FIGURE 10 SLEEP APNEA DEVICES MARKET, BY END USER, 2019 VS. 2024 (USD MILLION) 36
FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE SLEEP APNEA DEVICES MARKET 37
FIGURE 12 LARGE POOL OF UNDIAGNOSED SLEEP APNEA PATIENTS TO DRIVE THE MARKET FOR SLEEP APNEA DEVICES 38
FIGURE 13 THERAPEUTIC DEVICES WILL CONTINUE TO DOMINATE THE SLEEP APNEA DEVICES MARKET IN 2024 39
FIGURE 14 PAP DEVICES ACCOUNTED FOR THE LARGEST SHARE OF THE SLEEP APNEA THERAPEUTIC DEVICES MARKET IN 2018 39
FIGURE 15 SLEEP LABORATORIES & HOSPITALS ARE THE LARGEST END USERS OF SLEEP APNEA DEVICES 40
FIGURE 16 ASIA PACIFIC MARKET TO REGISTER THE HIGHEST GROWTH IN THE FORECAST PERIOD 41
FIGURE 17 OSA PREVALENCE ASSESSMENT (GLOBAL PERSPECTIVE) 51
FIGURE 18 THERAPEUTIC DEVICES TO COMMAND THE LARGEST SHARE OF THE GLOBAL SLEEP APNEA DEVICES MARKET IN 2018 59
FIGURE 19 ORAL APPLIANCES TO REGISTER THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 60
FIGURE 20 HOME SLEEP TESTING DEVICES TO REGISTER THE HIGHEST GROWTH RATE IN THE FORECAST PERIOD 79
FIGURE 21 SLEEP LABORATORIES & HOSPITALS SEGMENT TO COMMAND THE LARGEST SHARE OF THE GLOBAL SLEEP APNEA DEVICES MARKET IN 2019 91
FIGURE 22 NORTH AMERICA TO DOMINATE THE SLEEP APNEA DEVICES MARKET IN 2018 96
FIGURE 23 NORTH AMERICA: SLEEP APNEA DEVICES MARKET SNAPSHOT 98
FIGURE 24 EUROPE: SLEEP APNEA DEVICES MARKET SNAPSHOT 117
FIGURE 25 ASIA PACIFIC: SLEEP APNEA DEVICES MARKET SNAPSHOT 157
FIGURE 26 ROW: SLEEP APNEA DEVICES MARKET SNAPSHOT 188
FIGURE 27 KEY DEVELOPMENTS IN THE SLEEP APNEA DEVICES MARKET, 2016–2019 207
FIGURE 28 MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2018 208
FIGURE 29 SLEEP APNEA DEVICES MARKET (GLOBAL),
COMPETITIVE LEADERSHIP MAPPING, 2018 210
FIGURE 30 RESMED: COMPANY SNAPSHOT 213

FIGURE 31 KONINKLIJKE PHILIPS: COMPANY SNAPSHOT 219
FIGURE 32 FISHER & PAYKEL HEALTHCARE: COMPANY SNAPSHOT 224
FIGURE 33 SOMNOMED: COMPANY SNAPSHOT 227
FIGURE 34 OVENTUS MEDICAL: COMPANY SNAPSHOT 229
FIGURE 35 COMPUMEDICS: COMPANY SNAPSHOT 232


★調査レポート[睡眠時無呼吸症候群用装置の世界市場予測(~2024年)] ( Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device)), Diagnostic (PSG, Oximeter), End User (Sleep Laboratories & Hospitals, Home Care Settings/Individuals) - Global Forecasts to 2024 / MD 1181) 販売に関する免責事項
[睡眠時無呼吸症候群用装置の世界市場予測(~2024年)] ( Sleep Apnea Devices Market by Type, (Therapeutic (CPAP, APAP, Masks, ASV, Oral Appliances, Mandibular Advancement Device)), Diagnostic (PSG, Oximeter), End User (Sleep Laboratories & Hospitals, Home Care Settings/Individuals) - Global Forecasts to 2024 / MD 1181) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆